Почетна › Метастатски карцином › Северна Каролина › Durham
Клинички испитувања за Метастатски карцином во Durham, NC
33 студии за Метастатски карцином бараат учесници на локации во и околу Durham (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Се регрутираФаза 1/2
- Avenzo Therapeutics Recruiting Site, Chapel Hill · на 10 милји
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Се регрутираФаза 2
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Duke University, Durham
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Се регрутираФаза 2/3
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · на 10 милји
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Се регрутираФаза 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Се регрутираФаза 2
- Duke Cancer Institute, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Се регрутираФаза 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · на 10 милји
- University of North Carolina Hospitals at Hillsborough, Hillsborough · на 13 милји
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Се регрутираФаза 3
- Duke Cancer Institute, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Се регрутираФаза 3
- University of North Carolina Medical Center, Chapel Hill · на 10 милји
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · на 10 милји
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Се регрутираФаза 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · на 10 милји
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Duke University, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Се регрутира
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · на 10 милји
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Се регрутираФаза 1
- Duke Cancer Center, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Се регрутираФаза 1
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Се регрутираФаза 1
- Duke Cancer Center, Durham
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Се регрутираФаза 1/2
- Duke University Medical Center, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Се регрутираНабљудувачка студија
- University of North Carolina at Chapel Hill, Chapel Hill · на 10 милји
UNC Metastatic Cancer Radiation Therapy Registry
Се регрутираНабљудувачка студија
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · на 10 милји
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Се регрутираФаза 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · на 10 милји
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Се регрутираФаза 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Се регрутираФаза 2/3
- Duke University Medical Center, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Се регрутираФаза 1/2
- Duke Cancer Center/ DUMC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Се регрутираФаза 1
- Duke Cancer Institute, Durham
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Се регрутираФаза 3
- Duke University, Durham
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Се регрутираНабљудувачка студија
- Durham Veterans Administration Health Care System (DVAHCS), Durham
- Duke University Medical Center, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Се регрутираФаза 1
- Duke Cancer Center, Durham
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
Се регрутираФаза 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · на 10 милји
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Се регрутираФаза 1
- Duke University Medical Center - Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Chapel Hill · на 10 милји
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Се регрутираФаза 3
- Duke University - Trent Center, Durham
A Study of NX-1607 in Adults With Advanced Malignancies
Се регрутираФаза 1
- University of North Carolina, Chapel Hill · на 10 милји
Испитувања за Метастатски карцином во други градови
- Houston, TX104 студии
- New York City, NY93 студии
- Nashville, TN70 студии
- Boston, MA63 студии
- Los Angeles, CA57 студии
- St. Louis, MO54 студии
- Arlington, VA53 студии
- Philadelphia, PA46 студии
- Chicago, IL45 студии
- San Antonio, TX44 студии
- Washington, DC43 студии
- Dallas, TX42 студии
Други студии во Durham
- Рак на дојка64 студии
- Рак (сите типови)58 студии
- Рак на бели дробови со не-мали клетки39 студии
- Множен миелом37 студии
- Акутна миелоидна леукемија33 студии
- Рак на простата32 студии
- Рак на бели дробови32 студии
- Колоректален карцином28 студии
- Карцином на јајниците27 студии
- Хронична лимфоцитна леукемија27 студии
- Срцева слабост26 студии
- Карцином на панкреасот24 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.